Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Accumulated Expenses (2020 - 2023)

Historic Accumulated Expenses for Terns Pharmaceuticals (TERN) over the last 4 years, with Q3 2023 value amounting to $8.1 million.

  • Terns Pharmaceuticals' Accumulated Expenses rose 7058.45% to $8.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $8.1 million, marking a year-over-year increase of 7058.45%. This contributed to the annual value of $6.2 million for FY2022, which is 3127.4% up from last year.
  • Per Terns Pharmaceuticals' latest filing, its Accumulated Expenses stood at $8.1 million for Q3 2023, which was up 7058.45% from $8.0 million recorded in Q2 2023.
  • Over the past 5 years, Terns Pharmaceuticals' Accumulated Expenses peaked at $9.0 million during Q4 2020, and registered a low of $3.9 million during Q1 2022.
  • For the 4-year period, Terns Pharmaceuticals' Accumulated Expenses averaged around $6.0 million, with its median value being $5.0 million (2021).
  • Per our database at Business Quant, Terns Pharmaceuticals' Accumulated Expenses plummeted by 4787.92% in 2021 and then soared by 12451.96% in 2023.
  • Terns Pharmaceuticals' Accumulated Expenses (Quarter) stood at $9.0 million in 2020, then plummeted by 47.88% to $4.7 million in 2021, then skyrocketed by 31.27% to $6.2 million in 2022, then soared by 30.72% to $8.1 million in 2023.
  • Its Accumulated Expenses stands at $8.1 million for Q3 2023, versus $8.0 million for Q2 2023 and $8.8 million for Q1 2023.